Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA-Reference-Cited by-同舟云学术

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

Published:2001-08 Issue:12 Volume:15 Page:1517-1526
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Clumeck Nathan,Goebel Frank,Rozenbaum Willy,Gerstoft Jan,Staszewski Schlomo,Montaner Julio,Johnson Margaret,Gazzard Brian,Stone Chris,Athisegaran Rayma,Moore Sarah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference18 articles.

1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

2. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients

3. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

4. Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected AdultsA Randomized Equivalence Trial

5. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies

;HIV/AIDS - Research and Palliative Care;2020-10

2. Nucleoside inhibitors of reverse transcriptase as a basis for the first line anti-retroviral therapy of HIV infection;Clinical Medicine (Russian Journal);2017-08-04

3. Antiretroviral Agent;Clinical Virology;2016-03-07

4. Dyslipidemia in HIV;Lipid Management;2015

5. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study;HIV Medicine;2014-12-04